TS-005782 — This new IP introduces a modular, cell‑derived lipid nanoparticle (LNP) delivery platform engineered for highly efficient, biocompatible, and customizable delivery of nucleic acids and therapeutic agents, which is a significant improvement over existing synthetic LNP technologies.

TS-005781 — This invention introduces an advanced mRNA‑based gene‑therapy platform designed to treat both genetic and acquired elastin‑deficiency conditions, including autosomal dominant cutis laxa (ADCL), supravalvular aortic stenosis (SVAS), emphysema, aneurysms, and age‑related tissue degeneration. This IP represents a significant advancement over both plasmid‑based and existing mRNA therapies, establishing a safer, more effective strategy to address the root cause of elastin‑related diseases.

TS-005737 — This invention consists of prospectively collected natural history dataset capturing longitudinal functional and patient‑reported outcomes in patients with neuromuscular disorders, suspected neuromuscular disease, and healthy controls.

TS-005734 — This invention is a novel screening system designed to rapidly detect metallic foreign bodies such as esophageal coins, button batteries, and coin‑cell batteries in young children using advanced algorithms and technologies.

TS-005732 — A novel implantable tracheal splint that preserves the native mechanical and biological properties of the airway to treat conditions characterized by large‑airway collapse, such as congenital tracheobronchomalacia, tracheoesophageal fistula, and acquired infectious, autoimmune, neoplastic, or traumatic disorders.

TS-005728 — This novel external-mount valve connector is designed to simplify the testing and conditioning of tissue‑engineered heart valves (TEHVs) within pulsatile bioreactor systems. The device allows TEHVs to be rapidly affixed around a customizable 3D‑printed frame and directly integrated into standard tubing, eliminating the need for complex suturing, internal valve assembly, or custom‑molded housings used in conventional systems.

TS-005707 — This new machine learning based prediction tool can accurately model the binding strength between highly polymorphic natural killer (NK) cell KIR receptors and their equally diverse HLA class I ligands, incorporating not only the receptor and HLA sequences, but also the modulating peptide presented between them.

TS-005706 — This new instrument is designed to improve precision, stability, and ease of use during the placement of orthodontic elastics, particularly for individuals with craniofacial differences, dexterity challenges, or small pediatric oral anatomy with potential applications across orthodontic clinics, craniofacial centers, and home use as an alternative to traditional manual elastic placement methods.

TS-005676 — This new technology is a next‑generation adaptation of Rekovar’s Neomonki wearable platform, designed to enable early detection of necrotizing enterocolitis (NEC) by integrating advanced biosensors, imaging analysis, and a newly developed AI‑driven clinical algorithm to continuously monitor physiologic and behavioral signals to identify early signs of NEC far earlier than current tools such as Bell’s criteria, blood tests, or radiologic studies.

TS-005620 — This invention is an improved mandrel design that solves an issue encountered during the removal of seeded tissue‑engineered vascular grafts, where the adhesive force between the seeded scaffold and a smooth mandrel surface can be so strong that removal becomes difficult and may damage the scaffold. Unlike the existing mandrel, the new design incorporates longitudinal grooves and continuous ridges running parallel to the axis of removal. These structural features reduce the contact area between the scaffold and mandrel, lowering the friction and adhesive force. As a result, the improved mandrel allows the seeded scaffold to be removed with significantly less force, reducing the risk of scaffold damage and improving the reliability of the graft‑generation process.